Personalized and Connected Drug Delivery Systems

A novel system integrating drug delivery devices with pre-assembled cartridges and distinct technologies such as AI, IoT, blockchain, and novel materials to provide personalized, efficient, and secure treatment.

The original patent's drug delivery device with a pre-assembled cartridge has limitations in terms of precision, personalization, and security. The new inventive concept addresses these limitations by combining the patented device with advanced technologies to provide a more comprehensive and effective treatment solution.

The new system consists of a drug delivery device with a pre-assembled cartridge integrated with an AI-powered diagnostic module that analyzes patient data to optimize treatment parameters and pharmaceutical composition. The device is connected to an IoT network, enabling real-time monitoring and adjustment of treatment parameters based on patient feedback and environmental factors. Additionally, the system incorporates a blockchain-based platform for secure tracking and authentication of pharmaceuticals. The pre-assembled cartridge is made of a novel material composition designed to enhance pharmaceutical stability and bioavailability. The device utilizes a ratchet-based driver for consistent and controlled release of the pharmaceutical.

The new claims introduce novel and non-obvious combinations of the patented drug delivery device with distinct technologies, providing a synergistic effect that enhances the overall treatment experience. The integration of AI, IoT, blockchain, and novel materials creates a more personalized, efficient, and secure treatment solution.

Alternative embodiments of the inventive concept could include integrating the drug delivery device with other advanced technologies such as machine learning, natural language processing, or augmented reality. Variations of the system could be designed for specific disease treatments, patient populations, or medical specialties.

The inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of personalized medicine, precision drug delivery, and secure supply chain management. The target market includes pharmaceutical companies, hospitals, clinics, and medical research institutions.